This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Mar 11;137(10):1271-1272.

doi: 10.1182/blood.2020009281.

PD-1 blockade for untreated Hodgkin lymphoma

Alison J Moskowitz¹

Affiliations

PMID: 33704392
DOI: 10.1182/blood.2020009281

Free article

Comment

PD-1 blockade for untreated Hodgkin lymphoma

Alison J Moskowitz. Blood. 2021.

Free article

. 2021 Mar 11;137(10):1271-1272.

doi: 10.1182/blood.2020009281.

Author

Alison J Moskowitz¹

Affiliation

¹ Memorial Sloan Kettering Cancer Center.

PMID: 33704392
DOI: 10.1182/blood.2020009281

No abstract available

PubMed Disclaimer

Comment on

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma.
Allen PB, Savas H, Evens AM, Advani RH, Palmer B, Pro B, Karmali R, Mou E, Bearden J, Dillehay G, Bayer RA, Eisner RM, Chmiel JS, O'Shea K, Gordon LI, Winter JN. Allen PB, et al. Blood. 2021 Mar 11;137(10):1318-1326. doi: 10.1182/blood.2020007400. Blood. 2021. PMID: 32992341 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information